|
|
Volumn 22, Issue 10, 2001, Pages 357-359
|
|
What's new: newly approved drugs for children.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROSTANE DERIVATIVE;
ANTICONVULSIVE AGENT;
ATOVAQUONE;
ATOVAQUONE PLUS PROGUANIL;
BECLOMETASONE;
CARBAMAZEPINE;
DRUG DERIVATIVE;
FLUTICASONE SALMETEROL COMBINATION;
FLUTICASONE-SALMETEROL COMBINATION;
GLARGINE;
INSULIN;
LOPINAVIR;
METHYLPHENIDATE;
NAPHTHOQUINONE;
OXCARBAZEPINE;
PROGUANIL;
PROTEINASE INHIBITOR;
PYRIMIDINONE DERIVATIVE;
RITONAVIR;
SALBUTAMOL;
ADOLESCENT;
AGE;
ASTHMA;
ATTENTION DEFICIT DISORDER;
CHILD;
DELAYED RELEASE FORMULATION;
DRUG APPROVAL;
DRUG COMBINATION;
DRUG DELIVERY SYSTEM;
DRUG THERAPY;
FOCAL EPILEPSY;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
METHODOLOGY;
NEBULIZER;
PEDIATRICS;
REVIEW;
STANDARD;
STATISTICS;
UNITED STATES;
ADOLESCENT;
AGE FACTORS;
ALBUTEROL;
ANDROSTADIENES;
ANTICONVULSANTS;
ASTHMA;
ATOVAQUONE;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BECLOMETHASONE;
CARBAMAZEPINE;
CHILD;
CHLOROGUANIDE;
DELAYED-ACTION PREPARATIONS;
DIABETES MELLITUS, TYPE 1;
DRUG APPROVAL;
DRUG COMBINATIONS;
DRUG DELIVERY SYSTEMS;
DRUG THERAPY;
EPILEPSIES, PARTIAL;
HIV PROTEASE INHIBITORS;
HUMANS;
INSULIN;
METHYLPHENIDATE;
NAPHTHOQUINONES;
NEBULIZERS AND VAPORIZERS;
PEDIATRICS;
PYRIMIDINONES;
RITONAVIR;
UNITED STATES;
|
|
EID: 0035491781
PISSN: None
EISSN: 15263347
Source Type: Journal
DOI: 10.1542/pir.22-10-357 Document Type: Review |
|
Times cited : (3)
|
|
References (8)
|
